BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 12.8% of their position (7.29K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $670.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2026ACC: 0001197350-26-000006
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
-7.29K
Net shares
Net seller
$670.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.33K acquired · 20.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.33K
Price / share
—
Trade value
—
% of position
30.5%
3/15/2026
43.74K→57.08K
Common Stock
Direct
Shares
−7.29K
Price / share
$91.98
Trade value
$670.24K
% of position
12.8%
3/16/2026
57.08K→49.79K
Total
Net shares
+6.05K
Net value
-$670.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2026 | M · Option Exercise | +13.33K | — | — | 30.5% | 43.74K | 57.08K |
| Common Stock Direct | 3/16/2026 | S · Sale | −7.29K | $91.98 | $670.24K | 12.8% | 57.08K | 49.79K |
| Total | +6.05K | -$670.24K | ||||||
Derivative Transactions1
Performance Restricted Stock Units
Direct
Converts to
Common Stock
13.33K shares
Shares
−13.33K
Strike price
Held after
6.67K
Exercisable
—
3/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Restricted Stock Units Direct | Common Stock13.33K shares | 3/15/2026 | M · Option Exercise | −13.33K | — | 6.67K |